Correlation of pretransplant and early post‐transplant response assessment with outcomes after reduced‐intensity allogeneic hematopoietic stem cell transplantation for non‐Hodgkin's lymphoma

BACKGROUND: Chemotherapy sensitivity, defined simply as at least a partial response to chemotherapy, is an important outcome predictor for non‐Hodgkin lymphoma (NHL) patients undergoing reduced‐intensity allogeneic hematopoietic stem cell transplantation (allo‐HCT). The authors hypothesized that fur...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2010-02, Vol.116 (4), p.852-862
Hauptverfasser:	Bishop, Michael R., Dean, Robert M., Steinberg, Seth M., Odom, Jeanne, Pollack, Seth M., Pavletic, Steven Z., Sportes, Claude, Gress, Ronald E., Fowler, Daniel H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences chemotherapy sensitivity Clinical Trials as Topic Cyclophosphamide - therapeutic use Disease-Free Survival Doxorubicin - therapeutic use Etoposide - therapeutic use Female Hematologic and hematopoietic diseases hematopoietic stem cell transplantation Hematopoietic Stem Cell Transplantation - methods Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma, Non-Hodgkin - mortality Lymphoma, Non-Hodgkin - surgery Male Medical sciences Middle Aged nonmyeloablative non‐Hodgkin lymphoma Postoperative Period Prednisone - therapeutic use Preoperative Period reduced‐intensity Survival Rate Transplantation Conditioning Transplantation, Autologous Treatment Outcome Tumors Vincristine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!